Medication info
Telmira Plus Tablet 80/12.5 mg

Telmira Plus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White or almost white, round, biconvex tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201503336 · Approved 2015.05.29 · Insurance code 657805600

Summary

Main use
Treatment of essential hypertension inadequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Dosage Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this product may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given together as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this product. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. This product should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This product should be administered with caution to patients with mild to moderate hepatic impairment. The dose should not exceed 40/12.5mg once daily. This product should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.
Child dose
The safety and efficacy of this product have not been established in children under 18 years of age.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension. When essential hypertension is not adequately controlled by single medication, adding this medicine can lower blood pressure more effectively. It helps to ensure stable management of the patient's blood pressure and contributes to the prevention of cardiovascular complications. For safe and effective blood pressure management, please take it continuously.

How to take

Adult dose

Dosage Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this product may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given together as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this product. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. This product should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This product should be administered with caution to patients with mild to moderate hepatic impairment. The dose should not exceed 40/12.5mg once daily. This product should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.

Child dose

The safety and efficacy of this product have not been established in children under 18 years of age.

Precautions

This medication can pose significant risks to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It is safer not to use this medication during pregnancy, and pregnant or breastfeeding women should not take it. If there is an allergy to the active ingredient or additives of this medication, it must not be taken. This medication should not be administered to patients with severely impaired liver function or obstructive biliary disease. It is also prohibited for patients with very poor kidney function, acute nephritis, or anuria. Caution should be exercised in elderly patients or those with mildly impaired liver function, or in patients with hyperkalemia. Special attention is needed as excessively low blood pressure can cause issues with cardiac or cerebral circulation. Hydrochlorothiazide can respond sensitively to sunlight, so it is important to minimize UV exposure and regularly monitor the skin condition to reduce the risk of skin cancer. During treatment, adverse symptoms such as dizziness, fainting, visual disturbances, difficulty breathing, skin rash, etc., may occur; if any of these symptoms arise, consult a doctor immediately. This medication may interact with other blood pressure medications, diuretics, lithium preparations, potassium supplements, etc., so it is crucial to inform your healthcare provider of any other medications being taken, and regular monitoring of blood pressure and blood tests to check kidney function and electrolyte levels is necessary. Caution is required as dizziness or drowsiness may occur when driving or operating machinery. In case of overdose, symptoms of hypotension, electrolyte abnormalities, or dehydration may appear, so it is essential to adhere to the prescribed dosage and report any unusual symptoms to medical staff immediately. This medication is not used in children as its safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 107 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver injury
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • altered taste
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • weakness
  • influenza-like illness
  • increased creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute kidney injury
  • diabetes
  • weakness
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floating sensation
  • tremor of the lips and hands
  • hypersensitivity reaction
  • vision impairment
  • hypoglycemia
  • intestinal vascular edema
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is important to maintain a storage temperature between 1°C and 30°C to preserve the medication's effectiveness.

Appearance and packaging

Appearance

White or almost white, round, biconvex tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.